Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cassava Sciences Inc SAVA

Healthcare
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under... see more

Recent & Breaking News (NDAQ:SAVA)

22 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  September 18, 2017

NIH Awards $1.8 Million Research Grant to Pain Therapeutics in Support of a Blood-based Diagnostic for Alzheimer’s Disease

GlobeNewswire September 18, 2017

National Institute on Drug Abuse Awards Pain Therapeutics $2.2 Million Grant

GlobeNewswire September 18, 2017

Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update

GlobeNewswire August 9, 2017

Pain Therapeutics Announces FDA Has Cleared an Investigational New Drug (IND) Application for PTI-125

GlobeNewswire July 31, 2017

Breakfast Technical Briefing on Biotech Stocks -- Opko Health, Pain Therapeutics, Trevena, and Dynavax Technologies

PR Newswire June 20, 2017

NIH Awards $1.7 Million Research Grant to Pain Therapeutics to Study Alzheimer’s Disease

GlobeNewswire June 5, 2017

Pain Therapeutics Announces Research Publication on Alzheimer’s Disease

GlobeNewswire June 1, 2017

Pain Therapeutics Announces Reverse Stock Split

GlobeNewswire May 8, 2017

Research Reports Initiation on Biotech Stocks -- Trevena, Ocular Therapeutix, INSYS Therapeutics, and Pain Therapeutics

PR Newswire May 5, 2017

Pain Therapeutics Reports First Quarter 2017 Financial Results

GlobeNewswire April 25, 2017

Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY™ ER

GlobeNewswire March 20, 2017

Pain Therapeutics Reports 2016 Financial Results

GlobeNewswire February 17, 2017

Pain Therapeutics to Discuss REMOXY® ER with FDA

GlobeNewswire December 20, 2016

Research Reports Initiation on Biotech Stocks -- Pacific Biosciences of California, Aralez Pharma, Cerus, and Pain Therapeutics

PR Newswire December 19, 2016

Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain Therapeutics, Inc. Class Action and Settlement Hearing – PTIE

GlobeNewswire December 11, 2016

Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain Therapeutics, Inc. Class Action and Settlement Hearing – PTIE

GlobeNewswire November 11, 2016

Research Reports Initiation on Biotech Stocks -- Spectrum Pharma, Pain Therapeutics, CoLucid Pharma, and CEL-SCI

PR Newswire October 28, 2016

Pain Therapeutics Reports Q3 2016 Financial Results

GlobeNewswire October 20, 2016

Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain Therapeutics, Inc. Class Action and Settlement Hearing - PTIE

PR Newswire October 11, 2016